Publications by authors named "Aleksandr Pushkov"
Front Med (Lausanne)
November 2023
Article Synopsis
- The study investigates the safety and effectiveness of canakinumab for patients with undifferentiated autoinflammatory diseases (uAIDs), which had not been previously assessed.
- Data from 32 uAID patients were analyzed, revealing a range of symptoms and prior treatments before starting canakinumab, including fever, rash, and various organ involvements.
- Results showed that 84% of patients achieved complete remission, while a smaller percentage had partial or no response to the treatment.
